Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
about
Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteinsBreast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironmentPim Kinases Promote Migration and Metastatic Growth of Prostate Cancer XenograftsFGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cellsThe Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.Bevacizumab and breast cancer: current therapeutic progress and future perspectivesFast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts.Biomarkers for anti-angiogenic therapy in cancer.Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancerCelecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signalingSU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells.Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen.Clinical experience with ramucirumab : outcomes in breast cancer.Effects of bisphenol A and 17β-estradiol on vascular endothelial growth factor A and its receptor expression in the non-cancer and cancer ovarian cell lines.Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells.Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta.Effect of hypoxia on the release of vascular endothelial growth factor and testosterone in mouse TM3 Leydig cells.Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway.An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1.Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cellsPharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia.TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen.Sex differences in the alterations of Na(+), K(+)-ATPase following ischaemia-reperfusion injury in the rat kidney.Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis.Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer.Dynamics of IGF-1R expression during endocrine breast cancer treatment.Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.Molecular mechanisms of hormone resistance of breast cancer.
P2860
Q22254113-0E57F1E9-3A6F-47A4-94B3-4798D6E659EEQ24803543-1D26F570-581C-431F-AC82-216BD0402D8AQ27304359-B6DAFDB7-0497-4AE0-9864-2C955364BB29Q28203228-75EE5D9E-6CB3-4FEB-8924-EB4121E1BCA6Q30906575-756A16DA-608B-43CB-B6AB-1B2D61B9639CQ31132489-A51AB299-5790-4574-984A-83DC42C6D2FDQ32161271-D29B6808-0B6F-48EF-B372-169E29FDB430Q33372962-16EBD0CA-749E-48C6-B141-CF96EA626AE3Q33640753-F7D1ED67-7A9D-4207-8D75-D0E4A17D3F9AQ33733638-932E47B5-D5A9-4764-8B24-BF6BFCE67062Q34304087-64B84D2D-0226-4C34-ADE0-DF1617DB0C7AQ34695003-BC363D23-8F58-4786-B1EE-0AE73DCDD49FQ34725685-01F44B9A-707C-49CB-9BFC-685079E90F6DQ34753820-F8DEB74E-A73A-44C5-895D-1A1722931B04Q35592095-3141BB30-0F30-4B77-A4F9-EBC681BD3007Q36458731-4A51EB83-B228-4412-A7F9-FA1E61F5A7E9Q36670997-2FBD979D-42C9-4836-9F97-6F878EC8C7BCQ38228982-BB5F8F21-FAA8-4CB0-8DD8-546505A6CAA4Q38873842-C71F179F-49D6-4354-A807-8CE2ABD7DE58Q39192955-C1E6ABE6-7134-4182-88C3-DAD596ABB7E1Q39209023-FC2F1D7E-95E2-4AE6-A5FE-243BB1AE2F66Q39869920-A874A6ED-A705-423D-B105-197F9500744FQ40156352-D20478E0-14DE-41C6-9F1E-77468091BBC3Q40421578-AA43BDE3-7DD9-4733-AA45-3A0AFFD1D4B4Q40549904-693F3EED-11F8-496B-AA3E-5B36F57522ECQ40612609-6A85929B-55FD-4854-8EB0-2D57FE994BA4Q41129821-BD3A1327-79E2-4AE1-8A2F-11C09B5DB3D6Q42502853-706FBDCA-6C19-4420-9CFB-8D8680DAA323Q43716770-3514E125-B83B-4350-926D-B39858D5EB3EQ44513289-C76ECB49-72A5-4872-9406-D31A72D6FAA3Q44691684-560B32BA-E5B5-4020-8421-4AAA42F190B0Q45024315-DAFA1D84-3D97-4A80-903D-18EF9FBB85D8Q46209142-76038569-6492-4067-8C58-8A9F47AC8B97Q48225818-763F58EB-07B5-4174-89C5-B1C3A57EEA80Q51752849-1F7B44E0-AED0-439F-94A6-677C4EB4FC49Q51887729-621EAF4B-862E-42BA-B6EA-43D79869C284Q53086084-5679D3FB-4DC4-4172-94DF-831D9A28C911
P2860
Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
description
im März 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 1999
@uk
name
Vascular endothelial growth fa ...... trogens in breast cancer cells
@en
Vascular endothelial growth fa ...... trogens in breast cancer cells
@nl
type
label
Vascular endothelial growth fa ...... trogens in breast cancer cells
@en
Vascular endothelial growth fa ...... trogens in breast cancer cells
@nl
prefLabel
Vascular endothelial growth fa ...... trogens in breast cancer cells
@en
Vascular endothelial growth fa ...... trogens in breast cancer cells
@nl
P2093
P1476
Vascular endothelial growth fa ...... trogens in breast cancer cells
@en
P2093
J K Ruohola
M J Karkkainen
P L Härkönen
P356
10.1016/S0303-7207(99)00003-9
P50
P577
1999-03-01T00:00:00Z